InvestorsHub Logo
Followers 30
Posts 4136
Boards Moderated 0
Alias Born 07/25/2007

Re: None

Tuesday, 08/08/2023 4:13:30 PM

Tuesday, August 08, 2023 4:13:30 PM

Post# of 7786
The Q2 RVNC earnings report.

- Q2 total revenue of $58.1 million, a YoY increase of 104.9%.
- Q2 RHA® Collection revenue of $31.8 million, a YoY increase of 24.7%.
- Q2 DAXXIFY® revenue of $22.6 million, a QoQ increase of 47.1%.
- Bolstered financial position with $100 million net proceeds from ATM program and $50 million in notes available to be issued through Athyrium Capital on or before August 31, 2023.
- PDUFA date of August 19, 2023 for DAXXIFY® for the treatment of cervical dystonia.





https://investors.revance.com/news-releases/news-release-details/revance-reports-second-quarter-2023-financial-results-provides
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News